Cargando…

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

BACKGROUND: Evidence on factors associated with guideline-directed secondary prevention medication (GDPM) after percutaneous coronary intervention (PCI) and its effect on the prognosis of patients with coronary artery disease (CAD) is lacking in China. AIMS: To ascertain predictors of GDPM in real-w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tianyu, Tang, Xiaofang, Song, Ying, Yao, Yi, Zhao, Xueyan, Gao, Zhan, Yang, Yuejin, Gao, Runlin, Xu, Bo, Yuan, Jinqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719473/ https://www.ncbi.nlm.nih.gov/pubmed/35141130 http://dx.doi.org/10.5334/gh.812

Ejemplares similares

Long-Term Clinical Outcomes for Non-ST Elevation Acute Coronary Syndrome Patients with High-Risk Angiographic Findings Undergoing Percutaneous Coronary Intervention
por: Jia, Sida, et al.
Publicado: (2020)

Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention
por: Zhao, Xueyan, et al.
Publicado: (2019)

D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2020)

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study
por: Yuan, Deshan, et al.
Publicado: (2021)

Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World
por: Yan, Kailun, et al.
Publicado: (2023)

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention
por: Liu, Ru, et al.
Publicado: (2022)

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention
por: Li, Yulong, et al.
Publicado: (2022)

High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort
por: Wang, Peizhi, et al.
Publicado: (2022)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study
por: Li, Tianyu, et al.
Publicado: (2022)

A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2023)

Association of Baseline Smoking Status with Long-Term Prognosis in Patients Who Underwent Percutaneous Coronary Intervention: Large Single-Center Data
por: Liu, Ru, et al.
Publicado: (2019)

Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
por: Li, Jiawen, et al.
Publicado: (2021)

Susceptible gene polymorphism in patients with three-vessel coronary artery disease
por: Liu, Ru, et al.
Publicado: (2020)

Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China
por: Li, Jiawen, et al.
Publicado: (2023)

Association between inflammation, body mass index, and long-term outcomes in patients after percutaneous coronary intervention: A large cohort study
por: Zeng, Guyu, et al.
Publicado: (2023)

For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study
por: Liu, Ru, et al.
Publicado: (2023)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Comparison of Secondary Prevention Status between Percutaneous Coronary Intervention and Coronary Artery Bypass Patients
por: Gao, Xia-qing, et al.
Publicado: (2017)

Contrast Induced Nephropathy and 2-Year Outcomes of Iso-Osmolar Compared with Low-Osmolar Contrast Media after Elective Percutaneous Coronary Intervention
por: Du, Mengyang, et al.
Publicado: (2020)

Frequency and Predictors of Radial Artery Occlusion in Patients Undergoing Percutaneous Coronary Intervention
por: Munir, Ussama, et al.
Publicado: (2022)

5-Year Clinical Outcomes of Successful Recanalisation for Coronary Chronic Total Occlusions in Patients With or Without Type 2 Diabetes Mellitus
por: Wang, Peizhi, et al.
Publicado: (2021)

Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał A., et al.
Publicado: (2020)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
por: Zuhdi, AS, et al.
Publicado: (2013)

Association of prognostic nutritional index level and diabetes status with the prognosis of coronary artery disease: a cohort study
por: Li, Tianyu, et al.
Publicado: (2023)

Long-Term Clinical Outcomes of Unprotected Left Main Percutaneous Coronary Intervention: A Large Single-Centre Experience
por: Gao, Lijian, et al.
Publicado: (2021)

A risk score model of contrast-induced acute kidney injury in patients with emergency percutaneous coronary interventions
por: Yuan, Ying, et al.
Publicado: (2022)

Predictors of Inappropriately Rapid Coronary Lesion Progression in Patients Undergoing Percutaneous Coronary Interventions
por: Sella, Gal, et al.
Publicado: (2023)

Intravascular Ultrasound Guidance Improves the Long-term Prognosis in Patients with Unprotected Left Main Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Tian, Jian, et al.
Publicado: (2017)

Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study
por: Yuan, Deshan, et al.
Publicado: (2021)

Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry
por: Tang, Xiaofang, et al.
Publicado: (2021)

Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Park, Jangho, et al.
Publicado: (2021)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Predictors and Periprocedural Myocardial Injury Rate of Small Side Branches Occlusion in Coronary Bifurcation Intervention
por: Zhang, Dong, et al.
Publicado: (2015)

Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention
por: Jiang, Ping, et al.
Publicado: (2019)

Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome
por: Jia, Si-Da, et al.
Publicado: (2020)

Five-year outcomes of biodegradable versus second-generation durable polymer drug-eluting stents used in complex percutaneous coronary intervention
por: Xu, Na, et al.
Publicado: (2023)

Coronary artery lesion distribution in patients with chronic kidney disease undergoing percutaneous coronary intervention
por: Ikeda, Naofumi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bct50fes0o12ett0bk4bqf1p3n